Market Overview

KKR Appoints Mary Dillon as New Independent Director


KKR & Co. Inc. (NYSE:KKR) ("KKR") today announced that effective today,
Mary N. Dillon has been appointed to the Board of Directors of KKR. Her
appointment will bring the number of independent directors on KKR's
Board to eight out of a total of twelve Board seats.

Ms. Dillon is the Chief Executive Officer of Ulta Beauty, Inc., a
Fortune 500 retailer and the premier destination for cosmetics,
fragrance, skin, hair care products and services.

KKR's other independent directors include David Drummond (Senior Vice
President, Corporate Development and Chief Legal Officer of Alphabet
Inc.), Joseph Grundfest (Stanford Law Professor and former Commissioner
of the Securities and Exchange Commission), John Hess (Director and
Chief Executive Officer of Hess Corporation), Xavier Niel (Deputy
Chairman and Chief Strategy Officer of Iliad SA), Patricia Russo (former
Chief Executive Officer of Alcatel-Lucent), Thomas Schoewe (former Chief
Financial Officer of Walmart) and Robert Scully (former member of
the Office of the Chairman of Morgan Stanley).

About KKR

KKR is a leading global investment firm that manages multiple
alternative asset classes, including private equity, energy,
infrastructure, real estate and credit, with strategic manager
partnerships that manage hedge funds. KKR aims to generate attractive
investment returns for its fund investors by following a patient and
disciplined investment approach, employing world-class people, and
driving growth and value creation with KKR portfolio companies. KKR
invests its own capital alongside the capital it manages for fund
investors and provides financing solutions and investment opportunities
through its capital markets business. References to KKR's investments
may include the activities of its sponsored funds. For additional
information about KKR & Co. Inc. (NYSE:KKR), please visit KKR's website
and on Twitter @KKR_Co.

View Comments and Join the Discussion!
Fastest news service for the smartest traders
$147 Free 14 day Trial